{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:25:47Z","timestamp":1794540347968,"version":"4.9.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T00:00:00Z","timestamp":1589155200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai","doi-asserted-by":"publisher","award":["81641087"],"award-info":[{"award-number":["81641087"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Systemic sclerosis (SSc) or scleroderma is an intractable autoimmune disorder that affects multiple organs. The objectives were to investigate clinical correlations of serum calpain activity and high mobility group box 1 (HMGB1) levels with immunological and clinical traits.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A total of 31 patients with SSc, 20 age- and gender-matched healthy control subjects (HC), and 10 patients with other connective tissue diseases (CTD) were recruited in the study. We measured serum calpain activity and HMGB1 levels and analyzed the datasets (GSE40839, GSE48149, GSE76808, GSE81292, GSE33463, and GSE58095) from Gene Expression Omnibus (GEO) database to explore the potential mechanism by which calpain exerts its function through bioinformatics methods.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Serum calpain activity was significantly increased in patients with SSc compared with those in HC and in patients with CTD and was correlated with serum HMGB1 levels, modified Rodnan skin score, erythrocyte sedimentation rate, mean platelet volume, and plateletcrit. Notably, serum calpain activity and HMGB1 levels in SSc patients with interstitial lung disease (ILD) were significantly higher than those in SSc patients without ILD. Serum calpain activity and HMGB1 levels could be the independent risk factors for SSc-ILD and novel biomarkers in patients with SSc.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This is the first study that reports increased serum calpain activity and the correlation between calpain and HMGB1 in patients with SSc or SSc-ILD. The serum calpain activity and HMGB1 levels may serve as measures of ILD in patients with SSc. Also, calpain and HMGB1 could be potential therapeutic targets for patients with SSc or SSc-ILD in the future.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13075-020-02195-y","type":"journal-article","created":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T13:03:02Z","timestamp":1589202182000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Increased serum calpain activity is associated with HMGB1 levels in systemic sclerosis"],"prefix":"10.1186","volume":"22","author":[{"given":"Ji-Na","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Mei","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Qi","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0466-5013","authenticated-orcid":false,"given":"Qiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,5,11]]},"reference":[{"key":"2195_CR1","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1016\/S0140-6736(17)30933-9","volume":"390","author":"CP Denton","year":"2017","unstructured":"Denton CP, Khanna D. Systemic sclerosis. Lancet. 2017;390:1685\u201399.","journal-title":"Lancet"},{"key":"2195_CR2","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1172\/JCI31139","volume":"117","author":"J Varga","year":"2007","unstructured":"Varga J, Abraham D. Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest. 2007;117:557\u201367.","journal-title":"J Clin Invest"},{"key":"2195_CR3","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1007\/s00281-015-0551-z","volume":"38","author":"O Distler","year":"2016","unstructured":"Distler O, Cozzio A. Systemic sclerosis and localized scleroderma--current concepts and novel targets for therapy. Semin Immunopathol. 2016;38:87\u201395.","journal-title":"Semin Immunopathol"},{"key":"2195_CR4","doi-asserted-by":"publisher","first-page":"167sr1","DOI":"10.1126\/scitranslmed.3004700","volume":"5","author":"SL Friedman","year":"2013","unstructured":"Friedman SL, Sheppard D, Duffield JS, Violette S. Therapy for fibrotic diseases: nearing the starting line. Sci Transl Med. 2013;5:167sr1.","journal-title":"Sci Transl Med"},{"key":"2195_CR5","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1016\/j.autrev.2017.05.024","volume":"16","author":"Y Mostmans","year":"2017","unstructured":"Mostmans Y, Cutolo M, Giddelo C, Decuman S, Melsens K, Declercq H, Vandecasteele E, De Keyser F, Distler O, Gutermuth J, et al. The role of endothelial cells in the vasculopathy of systemic sclerosis: a systematic review. Autoimmun Rev. 2017;16:774\u201386.","journal-title":"Autoimmun Rev"},{"key":"2195_CR6","doi-asserted-by":"publisher","first-page":"835948","DOI":"10.1155\/2013\/835948","volume":"2013","author":"SA Jimenez","year":"2013","unstructured":"Jimenez SA. Role of endothelial to mesenchymal transition in the pathogenesis of the vascular alterations in systemic sclerosis. ISRN Rheumatol. 2013;2013:835948.","journal-title":"ISRN Rheumatol"},{"key":"2195_CR7","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/nrrheum.2014.137","volume":"10","author":"R Lafyatis","year":"2014","unstructured":"Lafyatis R. Transforming growth factor \u03b2--at the centre of systemic sclerosis. Nat Rev Rheumatol. 2014;10:706\u201319.","journal-title":"Nat Rev Rheumatol"},{"key":"2195_CR8","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1136\/annrheumdis-2016-210229","volume":"76","author":"M Manetti","year":"2017","unstructured":"Manetti M, Romano E, Rosa I, Guiducci S, Bellando-Randone S, De Paulis A, Ibba-Manneschi L, Matucci-Cerinic M. Endothelial-to-mesenchymal transition contributes to endothelial dysfunction and dermal fibrosis in systemic sclerosis. Ann Rheum Dis. 2017;76:924\u201334.","journal-title":"Ann Rheum Dis"},{"key":"2195_CR9","doi-asserted-by":"publisher","first-page":"3829","DOI":"10.1242\/jcs.02562","volume":"118","author":"SJ Franco","year":"2005","unstructured":"Franco SJ, Huttenlocher A. Regulating cell migration: calpains make the cut. J Cell Sci. 2005;118:3829\u201338.","journal-title":"J Cell Sci"},{"key":"2195_CR10","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1038\/nrd.2016.212","volume":"15","author":"Y Ono","year":"2016","unstructured":"Ono Y, Saido TC, Sorimachi H. Calpain research for drug discovery: challenges and potential. Nat Rev Drug Discov. 2016;15:854\u201376.","journal-title":"Nat Rev Drug Discov"},{"key":"2195_CR11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1152\/physrev.00029.2002","volume":"83","author":"DE Goll","year":"2003","unstructured":"Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev. 2003;83:731\u2013801.","journal-title":"Physiol Rev"},{"key":"2195_CR12","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1161\/CIRCHEARTFAILURE.115.002383","volume":"8","author":"R Ni","year":"2015","unstructured":"Ni R, Zheng D, Wang Q, Yu Y, Chen R, Sun T, Wang W, Fan GC, Greer PA, Gardiner RB, et al. Deletion of capn4 protects the heart against endotoxemic injury by preventing ATP synthase disruption and inhibiting mitochondrial superoxide generation. Circ Heart Fail. 2015;8:988\u201396.","journal-title":"Circ Heart Fail"},{"key":"2195_CR13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.2337\/db15-0963","volume":"65","author":"R Ni","year":"2016","unstructured":"Ni R, Zheng D, Xiong S, Hill DJ, Sun T, Gardiner RB, Fan GC, Lu Y, Abel ED, Greer PA, et al. Mitochondrial calpain-1 disrupts ATP synthase and induces superoxide generation in type 1 diabetic hearts: a novel mechanism contributing to diabetic cardiomyopathy. Diabetes. 2016;65:255\u201368.","journal-title":"Diabetes"},{"key":"2195_CR14","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1055\/s-2006-957332","volume":"27","author":"JC Horowitz","year":"2006","unstructured":"Horowitz JC, Thannickal VJ. Epithelial-mesenchymal interactions in pulmonary fibrosis. Semin Respir Crit Care Med. 2006;27:600\u201312.","journal-title":"Semin Respir Crit Care Med"},{"key":"2195_CR15","first-page":"1402","volume":"9","author":"WJ Tan","year":"2017","unstructured":"Tan WJ, Tan QY, Wang T, Lian M, Zhang L, Cheng ZS. Calpain 1 regulates TGF-\u03b21-induced epithelial-mesenchymal transition in human lung epithelial cells via PI3K\/Akt signaling pathway. Am J Transl Res. 2017;9:1402\u20139.","journal-title":"Am J Transl Res"},{"key":"2195_CR16","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s00125-019-4828-y","volume":"62","author":"X Teng","year":"2019","unstructured":"Teng X, Ji C, Zhong H, Zheng D, Ni R, Hill DJ, Xiong S, Fan GC, Greer PA, Shen Z, et al. Selective deletion of endothelial cell calpain in mice reduces diabetic cardiomyopathy by improving angiogenesis. Diabetologia. 2019;62:860\u201372.","journal-title":"Diabetologia."},{"key":"2195_CR17","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/cvr\/cvt048","volume":"98","author":"Y Wang","year":"2013","unstructured":"Wang Y, Zheng D, Wei M, Ma J, Yu Y, Chen R, Lacefield JC, Xu H, Peng T. Over-expression of calpastatin aggravates cardiotoxicity induced by doxorubicin. Cardiovasc Res. 2013;98:381\u201390.","journal-title":"Cardiovasc Res"},{"key":"2195_CR18","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature00858","volume":"418","author":"P Scaffidi","year":"2002","unstructured":"Scaffidi P, Misteli T, Bianchi ME. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature. 2002;418:191\u20135.","journal-title":"Nature"},{"key":"2195_CR19","doi-asserted-by":"publisher","first-page":"102701","DOI":"10.1016\/j.dnarep.2019.102701","volume":"83","author":"P Mandke","year":"2019","unstructured":"Mandke P, Vasquez KM. Interactions of high mobility group box protein 1 (HMGB1) with nucleic acids: implications in DNA repair and immune responses. DNA Repair (Amst). 2019;83:102701.","journal-title":"DNA Repair (Amst)"},{"key":"2195_CR20","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/s10875-008-9252-x","volume":"29","author":"A Yoshizaki","year":"2009","unstructured":"Yoshizaki A, Komura K, Iwata Y, Ogawa F, Hara T, Muroi E, Takenaka M, Shimizu K, Hasegawa M, Fujimoto M, et al. Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity. J Clin Immunol. 2009;29:180\u20139.","journal-title":"J Clin Immunol"},{"key":"2195_CR21","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/s41584-018-0072-y","volume":"14","author":"NJ Bernard","year":"2018","unstructured":"Bernard NJ. HMGB1(+) platelet microparticles damage the endothelium. Nat Rev Rheumatol. 2018;14:499.","journal-title":"Nat Rev Rheumatol"},{"key":"2195_CR22","doi-asserted-by":"crossref","unstructured":"Maugeri N, Capobianco A, Rovere-Querini P, Ramirez GA, Tombetti E, Valle PD, Monno A, D'Alberti V, Gasparri AM, Franchini S, et al. Platelet microparticles sustain autophagy-associated activation of neutrophils in systemic sclerosis. Sci Transl Med. 2018;10:eaao3089.","DOI":"10.1126\/scitranslmed.aao3089"},{"key":"2195_CR23","doi-asserted-by":"publisher","first-page":"584","DOI":"10.3109\/08916934.2012.719946","volume":"45","author":"N Maugeri","year":"2012","unstructured":"Maugeri N, Franchini S, Campana L, Baldini M, Ramirez GA, Sabbadini MG, Rovere-Querini P, Manfredi AA. Circulating platelets as a source of the damage-associated molecular pattern HMGB1 in patients with systemic sclerosis. Autoimmunity. 2012;45:584\u20137.","journal-title":"Autoimmunity"},{"key":"2195_CR24","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1182\/blood.V80.9.2246.2246","volume":"80","author":"JG Kelton","year":"1992","unstructured":"Kelton JG, Warkentin TE, Hayward CP, Murphy WG, Moore JC. Calpain activity in patients with thrombotic thrombocytopenic purpura is associated with platelet microparticles. Blood. 1992;80:2246\u201351.","journal-title":"Blood"},{"key":"2195_CR25","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1136\/annrheumdis-2013-204424","volume":"72","author":"F van den Hoogen","year":"2013","unstructured":"van den Hoogen F, Khanna D, Fransen J, Johnson SR, Baron M, Tyndall A, Matucci-Cerinic M, Naden RP, Medsger TA Jr, Carreira PE, et al. 2013 classification criteria for systemic sclerosis: an American college of rheumatology\/European league against rheumatism collaborative initiative. Ann Rheum Dis. 2013;72:1747\u201355.","journal-title":"Ann Rheum Dis"},{"key":"2195_CR26","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.1016\/j.jacc.2009.01.004","volume":"53","author":"VV McLaughlin","year":"2009","unstructured":"McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, MD MG, Park MH, Rosenson RS, et al. ACCF\/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol. 2009;53:1573\u2013619.","journal-title":"J Am Coll Cardiol"},{"key":"2195_CR27","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26:1572\u20133.","journal-title":"Bioinformatics"},{"key":"2195_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1093\/cvr\/cvs099","volume":"96","author":"E Letavernier","year":"2012","unstructured":"Letavernier E, Zafrani L, Perez J, Letavernier B, Haymann JP, Baud L. The role of calpains in myocardial remodelling and heart failure. Cardiovasc Res. 2012;96:38\u201345.","journal-title":"Cardiovasc Res"},{"key":"2195_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5551\/jat.RV17008","volume":"25","author":"T Miyazaki","year":"2018","unstructured":"Miyazaki T, Miyazaki A. Dysregulation of calpain proteolytic systems underlies degenerative vascular disorders. J Atheroscler Thromb. 2018;25:1\u201315.","journal-title":"J Atheroscler Thromb"},{"key":"2195_CR30","first-page":"1796","volume":"2015","author":"FZ Li","year":"1852","unstructured":"Li FZ, Cai PC, Song LJ, Zhou LL, Zhang Q, Rao SS, Xia Y, Xiang F, Xin JB, Greer PA, et al. Crosstalk between calpain activation and TGF-beta1 augments collagen-I synthesis in pulmonary fibrosis. Biochim Biophys Acta. 1852;2015:1796\u2013804.","journal-title":"Biochim Biophys Acta"},{"key":"2195_CR31","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1007\/s00210-018-1499-z","volume":"391","author":"Y Liu","year":"2018","unstructured":"Liu Y, Liu B, Zhang GQ, Zou JF, Zou ML, Cheng ZS. Calpain inhibition attenuates bleomycin-induced pulmonary fibrosis via switching the development of epithelial-mesenchymal transition. Naunyn Schmiedeberg's Arch Pharmacol. 2018;391:695\u2013704.","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol"},{"key":"2195_CR32","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1111\/j.1365-2249.2010.04257.x","volume":"162","author":"C Tabata","year":"2010","unstructured":"Tabata C, Tabata R, Nakano T. The calpain inhibitor calpeptin prevents bleomycin-induced pulmonary fibrosis in mice. Clin Exp Immunol. 2010;162:560\u20137.","journal-title":"Clin Exp Immunol"},{"key":"2195_CR33","first-page":"1402","volume":"9","author":"WJ Tan","year":"2017","unstructured":"Tan WJ, Tan QY, Wang T, Lian M, Zhang L, Cheng ZS. Calpain 1 regulates TGF-beta1-induced epithelial-mesenchymal transition in human lung epithelial cells via PI3K\/Akt signaling pathway. Am J Transl Res. 2017;9:1402\u20139.","journal-title":"Am J Transl Res"},{"key":"2195_CR34","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pupt.2017.10.012","volume":"48","author":"LJ Song","year":"2018","unstructured":"Song LJ, Xiang F, Ye H, Huang H, Yang J, Yu F, Xiong L, Xu JJ, Greer PA, Shi HZ, et al. Inhibition of angiotensin II and calpain attenuates pleural fibrosis. Pulm Pharmacol Ther. 2018;48:46\u201352.","journal-title":"Pulm Pharmacol Ther"},{"key":"2195_CR35","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.autrev.2018.01.012","volume":"17","author":"M Scherlinger","year":"2018","unstructured":"Scherlinger M, Guillotin V, Truchetet ME, Contin-Bordes C, Sisirak V, Duffau P, Lazaro E, Richez C, Blanco P. Systemic lupus erythematosus and systemic sclerosis: all roads lead to platelets. Autoimmun Rev. 2018;17:625\u201335.","journal-title":"Autoimmun Rev"},{"key":"2195_CR36","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1002\/art.23735","volume":"58","author":"S Guiducci","year":"2008","unstructured":"Guiducci S, Distler JH, Jungel A, Huscher D, Huber LC, Michel BA, Gay RE, Pisetsky DS, Gay S, Matucci-Cerinic M, et al. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis. Arthritis Rheum. 2008;58:2845\u201353.","journal-title":"Arthritis Rheum"},{"key":"2195_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161436","volume":"11","author":"X Shu","year":"2016","unstructured":"Shu X, Peng Q, Lu X, Wang G. HMGB1 may be a biomarker for predicting the outcome in patients with polymyositis \/dermatomyositis with interstitial lung disease. PLoS One. 2016;11:e0161436.","journal-title":"PLoS One"},{"key":"2195_CR38","doi-asserted-by":"crossref","first-page":"4338","DOI":"10.18632\/aging.102052","volume":"11","author":"J Ji","year":"2019","unstructured":"Ji J, Fu T, Dong C, Zhu W, Yang J, Kong X, Zhang Z, Bao Y, Zhao R, Ge X, et al. Targeting HMGB1 by ethyl pyruvate ameliorates systemic lupus erythematosus and reverses the senescent phenotype of bone marrow-mesenchymal stem cells. Aging (Albany NY). 2019;11:4338\u201353.","journal-title":"Aging (Albany NY)"},{"key":"2195_CR39","doi-asserted-by":"publisher","first-page":"487","DOI":"10.3109\/08916934.2014.921811","volume":"47","author":"DS Pisetsky","year":"2014","unstructured":"Pisetsky DS. The complex role of DNA, histones and HMGB1 in the pathogenesis of SLE. Autoimmunity. 2014;47:487\u201393.","journal-title":"Autoimmunity"},{"key":"2195_CR40","doi-asserted-by":"publisher","first-page":"257","DOI":"10.4103\/jpgm.JPGM_499_16","volume":"63","author":"CS Syahidatulamali","year":"2017","unstructured":"Syahidatulamali CS, Wan Syamimee WG, Azwany YN, Wong KK, Che Maraina CH. Association of anti-CLIC2 and anti-HMGB1 autoantibodies with higher disease activity in systemic lupus erythematosus patients. J Postgrad Med. 2017;63:257\u201361.","journal-title":"J Postgrad Med"},{"key":"2195_CR41","doi-asserted-by":"publisher","first-page":"5230374","DOI":"10.1155\/2017\/5230374","volume":"2017","author":"F Biscetti","year":"2017","unstructured":"Biscetti F, Flex A, Alivernini S, Tolusso B, Gremese E, Ferraccioli G. The role of high-mobility group box-1 and its crosstalk with microbiome in rheumatoid arthritis. Mediat Inflamm. 2017;2017:5230374.","journal-title":"Mediat Inflamm"},{"key":"2195_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1084\/jem.20141318","volume":"212","author":"H Yang","year":"2015","unstructured":"Yang H, Wang H, Ju Z, Ragab AA, Lundback P, Long W, Valdes-Ferrer SI, He M, Pribis JP, Li J, et al. MD-2 is required for disulfide HMGB1-dependent TLR4 signaling. J Exp Med. 2015;212:5\u201314.","journal-title":"J Exp Med"},{"key":"2195_CR43","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1111\/adb.12365","volume":"22","author":"M Anton","year":"2017","unstructured":"Anton M, Alen F, Gomez de Heras R, Serrano A, Pavon FJ, Leza JC, Garcia-Bueno B, Rodriguez de Fonseca F, Orio L. Oleoylethanolamide prevents neuroimmune HMGB1\/TLR4\/NF-kB danger signaling in rat frontal cortex and depressive-like behavior induced by ethanol binge administration. Addict Biol. 2017;22:724\u201341.","journal-title":"Addict Biol"},{"key":"2195_CR44","doi-asserted-by":"crossref","unstructured":"Koh WU, Kim J, Lee J, Song GW, Hwang GS, Tak E, Song JG. Remote ischemic preconditioning and diazoxide protect from hepatic ischemic reperfusion injury by inhibiting HMGB1-induced TLR4\/MyD88\/NF-kappaB signaling. Int J Mol Sci. 2019;20:5899.","DOI":"10.3390\/ijms20235899"},{"key":"2195_CR45","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.brainresbull.2017.05.004","volume":"132","author":"AH Liu","year":"2017","unstructured":"Liu AH, Wu YT, Wang YP. MicroRNA-129-5p inhibits the development of autoimmune encephalomyelitis-related epilepsy by targeting HMGB1 through the TLR4\/NF-kB signaling pathway. Brain Res Bull. 2017;132:139\u201349.","journal-title":"Brain Res Bull"},{"key":"2195_CR46","doi-asserted-by":"publisher","first-page":"27480","DOI":"10.1074\/jbc.M112.358929","volume":"287","author":"J Ma","year":"2012","unstructured":"Ma J, Wei M, Wang Q, Li J, Wang H, Liu W, Lacefield JC, Greer PA, Karmazyn M, Fan GC, et al. Deficiency of Capn4 gene inhibits nuclear factor-kappaB (NF-kappaB) protein signaling\/inflammation and reduces remodeling after myocardial infarction. J Biol Chem. 2012;287:27480\u20139.","journal-title":"J Biol Chem"},{"key":"2195_CR47","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1164\/rccm.201903-0563CI","volume":"201","author":"D Khanna","year":"2020","unstructured":"Khanna D, Tashkin DP, Denton CP, Renzoni EA, Desai SR, Varga J. Etiology, risk factors, and biomarkers in systemic sclerosis with interstitial lung disease. Am J Respir Crit Care Med. 2020;201:650\u201360.","journal-title":"Am J Respir Crit Care Med"},{"key":"2195_CR48","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/S0002-9343(97)00023-5","volume":"103","author":"G Spencer-Green","year":"1997","unstructured":"Spencer-Green G, Alter D, Welch HG. Test performance in systemic sclerosis: anti-centromere and anti-Scl-70 antibodies. Am J Med. 1997;103:242\u20138.","journal-title":"Am J Med"}],"container-title":["Arthritis Research &amp; Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02195-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13075-020-02195-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-020-02195-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,23]],"date-time":"2022-10-23T08:48:16Z","timestamp":1666514896000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-020-02195-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,11]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["2195"],"URL":"https:\/\/doi.org\/10.1186\/s13075-020-02195-y","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-16478\/v1","asserted-by":"object"},{"id-type":"doi","id":"10.21203\/rs.3.rs-16478\/v2","asserted-by":"object"}]},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,11]]},"assertion":[{"value":"3 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 May 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was carried out in accordance with the recommendations of Zhongshan Hospital Research Ethics Committee. The protocol was approved by the Ethical Committee of Zhongshan Hospital with the approval number-B2019-192R. The written informed consent was obtained from all patients.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all participants for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"110"}}